UltimoVacs ASA：邀请参加2022年第一季度业绩网络直播演示

Ultimovacs ASA: Invitation to first quarter 2022 results webcast presentation

Oslo, 5 May 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, invites to a webcast presentation of its first quarter 2022 results on Thursday 12 May 2022.

The presentation can be followed as a live webcast accessed through a link on at 13:00 CET on Thursday 12 May 2022. The webcast presentation will be available on the Ultimovacs website, and it will be possible to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 08:00 CET the same day.

For further information, please see or contact:

Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507

Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632

Anne Worsøe, Head of IR & Communication
Email: anne.worsoe@ultimovacs.com
Phone: +47 906 86815